Freeline Receives Approval to Transfer to Nasdaq Capital Market

November 29, 2022

https://www.globenewswire.com/news-release/2022/11/29/2564489/0/en/Freeline-Receives-Approval-to-Transfer-to-Nasdaq-Capital-Market.html

LONDON, Nov. 29, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq:FRLN) (the “Company” or “Freeline”) today announced that it received approval from the Nasdaq Stock Market LLC (“Nasdaq”) to transfer the listing of its American Depositary Shares (“ADSs”) representing ordinary shares of the Company from The Nasdaq Global Select Market to The Nasdaq Capital Market. The transfer will be effective at the opening of business on November 30, 2022. The Company will continue to trade under the symbol “FRLN.”

Read more at globenewswire.com

Related news for (FRLN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.